Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Design of a Targeted Covalent Probe to Interrogate the DNA Polymerase Activity of Polθ.

ACS medicinal chemistry letters·2026
Same author

The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ ATPase Inhibitor.

Journal of medicinal chemistry·2025
Same author

Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor.

Journal of medicinal chemistry·2025
Same author

Multiscale modeling shows how 2'-deoxy-ATP rescues ventricular function in heart failure.

Proceedings of the National Academy of Sciences of the United States of America·2024
Same author

Dilated cardiomyopathy mutation in beta-cardiac myosin enhances actin activation of the power stroke and phosphate release.

PNAS nexus·2024
Same author

Targeting Tuberculosis: Novel Scaffolds for Inhibiting Cytochrome <i>bd</i> Oxidase.

Journal of chemical information and modeling·2024

Video Experimental Relacionado

Updated: Jul 7, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Diseño computacional de fármacos que acomode la flexibilidad del receptor: el esquema complejo relajado.

Jung-Hsin Lin1, Alexander L Perryman, Julie R Schames

  • 1Howard Hughes Medical Institute, Department of Chemistry & Biochemistry, and Department of Pharmacology, University of California at San Diego, 92093-0365, USA. jlin@maccammon.ucsd.edu

Journal of the American Chemical Society
|May 16, 2002
PubMed
Resumen

Un nuevo método computacional de diseño de fármacos, "complejo relajado", explica la flexibilidad del receptor. Identifica los modos óptimos de unión ligando-enzima, lo que permite el desarrollo de fármacos potentes.

Más Videos Relacionados

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Videos de Experimentos Relacionados

Last Updated: Jul 7, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Área de la Ciencia:

  • Química computacional es la química computacional.
  • Descubrimiento de fármacos.
  • Biología estructural Biología estructural.

Sus antecedentes:

  • La flexibilidad del receptor es crucial en el diseño de fármacos, sin embargo, los métodos tradicionales a menudo lo pasan por alto.
  • La unión de ligandos puede ser sensible a las raras conformaciones de los receptores.
  • Los métodos experimentales existentes como SAR por RMN y el tethering ofrecen enfoques basados en bloques de construcción.

Objetivo del estudio:

  • Introducir una nueva metodología computacional para el diseño de fármacos que incorpore la flexibilidad del receptor.
  • Abordar las limitaciones de los métodos computacionales existentes en el modelado de interacciones dinámicas receptor-ligando.
  • Proporcionar un análogo computacional a las técnicas experimentales de relación estructura-actividad.

Principales métodos:

  • El estudio describe un método computacional "relajado-complejo".
  • Este enfoque modela la unión de ligandos a conformaciones de receptores potencialmente raras.
  • Analiza la sensibilidad de los modos de unión ligando-enzima a las conformaciones enzimáticas.

Principales resultados:

  • El método del complejo relajado identifica con éxito los complejos óptimos de ligando-enzima.
  • El enfoque demuestra el impacto significativo de las conformaciones enzimáticas en los modos de unión.
  • Ofrece una estrategia computacional para diseñar fármacos potentes.

Conclusiones:

  • El método de complejo relajado es un avance significativo en el diseño computacional de fármacos.
  • Esta metodología permite el descubrimiento de fármacos altamente efectivos considerando la dinámica de los receptores.
  • Sirve como una valiosa herramienta computacional para el desarrollo de fármacos basados en la estructura.